Researchers found that CXCL1, a protein produced by spinal cord tissue, contributes to opioid tolerance.
“By neutralizing CXCL1 in patients, we might help solve the problem of opioid tolerance,” said Chih-Peng Lin, MD, assistant professor, department of anesthesiology, National Taiwan University College of Medicine. “By suppressing opioid tolerance, we can help patients achieve prolonged pain relief without the side effects of increased opioid dosages.”
However, study authors note that further research must be done to determine whether blocking the protein is a safe and effective way to eliminate opioid tolerance.
More articles on anesthesia:
Dr. Scott Klier joins Silver Cross Hospital
UC Health names Dr. William Hurford inaugural CMO
Top 5 causes of anesthesiologist burnout
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.